{'52WeekChange': -0.8000002,
 'SandP52WeekChange': None,
 'address1': '5777 Central Avenue',
 'address2': 'Suite 102',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 0.905,
 'askSize': 900,
 'averageDailyVolume10Day': 1460225,
 'averageVolume': 1680206,
 'averageVolume10days': 1460225,
 'beta': None,
 'beta3Year': None,
 'bid': 0.905,
 'bidSize': 800,
 'bookValue': 2.333,
 'category': None,
 'circulatingSupply': None,
 'city': 'Boulder',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 0.93,
 'dayLow': 0.88,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -0.077,
 'enterpriseToRevenue': 0.33,
 'enterpriseValue': 1804875,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.0882857,
 'fiftyTwoWeekHigh': 6.5100064,
 'fiftyTwoWeekLow': 0.71,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 8529152,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 15,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.14307,
 'heldPercentInstitutions': 0.31986,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1567468800,
 'lastSplitFactor': '1:7',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/brickellbio.com',
 'longBusinessSummary': 'Brickell Biotech, Inc., a clinical-stage '
                        'pharmaceutical company, focuses on the development of '
                        'various prescription therapeutics for the treatment '
                        'of debilitating skin diseases in the United States. '
                        "The company's lead products candidate is sofpironium "
                        'bromide that is in Phase III clinical trial for '
                        'patients with axillary hyperhidrosis. It is also '
                        'developing therapeutics for cutaneous T-cell '
                        'lymphoma, psoriasis, and other dermatological '
                        'conditions. The company was founded in 2009 and is '
                        'based in Boulder, Colorado.',
 'longName': 'Brickell Biotech, Inc.',
 'market': 'us_market',
 'marketCap': 22250462,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_109767483',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -23645000,
 'nextFiscalYearEnd': 1640908800,
 'open': 0.93,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '720-505-4755',
 'previousClose': 0.938,
 'priceHint': 4,
 'priceToBook': 0.3898414,
 'priceToSalesTrailing12Months': 4.0669827,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 0.93,
 'regularMarketDayLow': 0.88,
 'regularMarketOpen': 0.93,
 'regularMarketPreviousClose': 0.938,
 'regularMarketPrice': 0.93,
 'regularMarketVolume': 794525,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 24464500,
 'sharesPercentSharesOut': 0.0139,
 'sharesShort': 134439,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 62792,
 'shortName': 'Brickell Biotech, Inc.',
 'shortPercentOfFloat': 0.0172,
 'shortRatio': 0.04,
 'startDate': None,
 'state': 'CO',
 'strikePrice': None,
 'symbol': 'BBI',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -3.167,
 'twoHundredDayAverage': 1.3948201,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'f4528711-5e01-3c7e-b315-947636e61548',
 'volume': 794525,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.brickellbio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '80301'}